Medical service provider Linkedcare has pocketed over 200 million yuan ($30 million) in its Series C2 round co-led by Lightspeed China Partners and SoYoung, while METiS Pharmaceuticals has closed two rounds of financing raising over 100 million yuan ($15 million).
Lightspeed co-leads $30m funding in Linkedcare
Linkedcare, a medical service provider that specialises in software-as-a-service (SaaS), has raised over 200 million yuan ($30 million) in its Series C2 round of financing jointly led by Chinese early-stage-focused venture capital firm Lightspeed China Partners and Nasdaq-listed medical cosmetology player SoYoung.